Theranostic cancer applications utilized by nanoparticles offering multimodal systems and future insights

被引:0
|
作者
Emir Yasun
机构
[1] University of California Santa Barbara,Department of Mechanical Engineering and California NanoSystems Institute (CNSI)
来源
SN Applied Sciences | 2020年 / 2卷
关键词
Theranostics; Multimodal theranostics; Diagnosis; Cancer therapy; Nanotechnology; CRISPR;
D O I
暂无
中图分类号
学科分类号
摘要
Recent studies showed that imaging-guided cancer therapeutics have higher success rates so instead of using a single modality, the combination of diagnosis and therapy (theranostic) modalities have simultaneously been employed more often for the cancer treatments. Also, instead of employing single modality, combination of more than one modality for each cancer diagnosis and therapy becomes to be the route for the scientists study in the field of theranostics and applied nanotechnology due to the improved theranostic efficiency. Purpose-oriented fabricated nanoparticles are usually chosen as carriers and contrast agents for those multimodal theranostic systems owing to their unique optoelectronic (optical-electronic) and physical properties. This is a mini review as a general synopsis of the recent applications of nanoparticles as one of the most efficient cancer theranostic agents and future insights for theranostics.
引用
收藏
相关论文
共 50 条
  • [1] Theranostic cancer applications utilized by nanoparticles offering multimodal systems and future insights
    Yasun, Emir
    SN APPLIED SCIENCES, 2020, 2 (09):
  • [2] Theranostic applications of nanoparticles in cancer
    Ahmed, Naveed
    Fessi, Hatem
    Elaissari, Abdelhamid
    DRUG DISCOVERY TODAY, 2012, 17 (17-18) : 928 - 934
  • [3] Foundational insights for theranostic applications of magnetoelectric nanoparticles
    Andre, Victoria
    Abdel-Mottaleb, Mostafa
    Shotbolt, Max
    Chen, Shawnus
    Ramezini, Zeinab
    Zhang, Elric
    Conlan, Skye
    Telisman, Ozzie
    Liang, Ping
    Bryant, John M.
    Chomko, Roman
    Khizroev, Sakhrat
    NANOSCALE HORIZONS, 2025,
  • [4] Theranostic Nanoparticles for Cancer and Cardiovascular Applications
    Dan Wang
    Bingbing Lin
    Hua Ai
    Pharmaceutical Research, 2014, 31 : 1390 - 1406
  • [5] Theranostic Nanoparticles for Cancer and Cardiovascular Applications
    Wang, Dan
    Lin, Bingbing
    Ai, Hua
    PHARMACEUTICAL RESEARCH, 2014, 31 (06) : 1390 - 1406
  • [6] Casein modified gold nanoparticles for future theranostic applications
    Espinoza-Castaneda, Marisol
    de la Escosura-Muniz, Alfredo
    Gonzalez-Ortiz, Gemma
    Martin-Orue, Susana M.
    Francisco Perez, Jose
    Merkoci, Arben
    BIOSENSORS & BIOELECTRONICS, 2013, 40 (01): : 271 - 276
  • [7] Theranostic applications of organic nanoparticles for cancer treatment
    Yhee, Ji Young
    Son, Sohee
    Kim, Namho
    Choi, Kuiwon
    Kwon, Ick Chan
    MRS BULLETIN, 2014, 39 (03) : 239 - 249
  • [8] Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications
    Ferro-Flores, Guillermina
    Ancira-Cortez, Alejandra
    Ocampo-Garcia, Blanca
    Melendez-Alafort, Laura
    NANOMATERIALS, 2024, 14 (03)
  • [9] Photoluminescent biocompatible silicon nanoparticles for cancer theranostic applications
    Osminkina, Liubov A.
    Tamarov, Konstantin P.
    Sviridov, Andrey P.
    Galkin, Rostislav A.
    Gongalsky, Maxim B.
    Solovyev, Valery V.
    Kudryavtsev, Andrey A.
    Timoshenko, Victor Yu.
    JOURNAL OF BIOPHOTONICS, 2012, 5 (07) : 529 - 535
  • [10] Cancer theranostic applications of lipid-based nanoparticles
    Tang, Wei-Lun
    Tang, Wei-Hsin
    Li, Shyh-Dar
    DRUG DISCOVERY TODAY, 2018, 23 (05) : 1159 - 1166